Fluzone Quadrivalent achieved noninferiority for HI antibody GMTs 21 days after vaccination compared to those following TIV for all 4 strains. Fluzone Quadrivalent achieved noninferiority for ...
SWIFTWATER, Pa., Nov. 3, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has ...
SWIFTWATER, Pa., June 17, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research has granted approval to Sanofi Pasteur, the vaccines global ...
Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent are vaccines indicated for immunization against disease caused by influenza A and B strains contained in the vaccine.
- Fluzone® Intradermal (Influenza Virus Vaccine) first to offer an immunization option with 90 percent smaller needle - Swiftwater, Pa - May 10, 2011 /PRNewswire/ - Sanofi Pasteur, the vaccines ...
PARIS, Nov. 4, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for ...
Quadrivalent inactivated "split virus" influenza vaccine (Types A and B); 0.25mL dose contains a total of 30mcg of influenza virus hemmagglutinin; 0.5mL dose contains a total of 60mcg of influenza ...
SWIFTWATER, Pa., June 17, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research has granted approval to Sanofi Pasteur, the vaccines global ...
FDA approves Fluzone ® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older *Will be available in fall 2020, in time for the 2020-2021 flu season PARIS - November 4, 2019 – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results